Table 2 Relation among GAD level, PHQ-15 level and antenatal depression
Characteristics | Total sample (n = 5728) | PHQ-9 ≥ 10 (n = 933) | PHQ-9 < 10 (n = 4795) | X2 | P |
|---|---|---|---|---|---|
GAD level, No. (%) | Â | Â | Â | 1173.408 | < 0.001* |
 No anxiety symptoms | 4396 (76.7) | 368 (39.4) | 4028 (84.0) |  |  |
 Mild anxiety | 1080 (18.9) | 367 (39.3) | 713 (14.9) |  |  |
 Moderate anxiety | 154 (2.7) | 114 (12.2) | 40 (0.8) |  |  |
 Moderate-severe anxiety | 77 (1.3) | 65 (7.0) | 12 (0.3) |  |  |
 Severe anxiety | 21 (0.4) | 19 (2.0) | 2 (0.0) |  |  |
PHQ-15 level, No. (%) | Â | Â | Â | 1021.353 | < 0.001* |
 No somatic symptoms | 1905 (33.3) | 52 (5.6) | 1853 (38.6) |  |  |
 Mild somatic symptoms | 2352 (41.1) | 300 (32.2) | 2052 (42.8) |  |  |
 Moderate somatic symptoms | 1165 (20.3) | 387 (41.5) | 778 (16.2) |  |  |
 Severe somatic symptoms | 306 (5.3) | 194 (20.8) | 112 (2.3) |  |  |